Markets

PRA Health, AMR Team Up to Advance Vaccine Studies

PRA Health Sciences, Inc.PRAH recently announced a partnership with Alliance for Multispecialty Research (AMR) in order to bring new vaccines in the market. This collaboration will certainly facilitate a better approach toward vaccine studies, yielding more efficient as well as effective results.

The strategic collaboration will ease the classification of suitable patient populations for vaccine studies. As a result, new vaccines will be developed and rolled out in the market in much less time.

When it comes to vaccine studies, PRA Health possesses noteworthy expertise. The company had previously conducted Phase I-Phase IV adult and pediatric studies at more than 3,000 sites, which involved close to 213,000 participants. In addition to that, the contract research organization has provided clinical development support for ten permitted vaccines over the last five years. Presently four of the top five vaccine manufacturers are supported by PRA Health.

The teamwork between PRA Health and AMR will provide ample support to vaccine trials, small or medium in size. AMR, known for its experienced clinical research centers, boasts an impressive 98% subject retention rate. This is expected to assist sponsors meet or exceed enrollment timelines.

We believe this is an important stride for PRA Health as this partnership will open up avenues for better visibility. Although the vaccine market has been conventionally pediatric in nature, the adult vaccine market is growing with each passing day. In fact, the market value is expected to nearly double by 2020.

Zacks Rank and Other Key Picks

Currently, Veeva carries a Zacks Rank #2 (Buy). Other well-placed stocks in the medical sector are Masimo MASI , Thoratec THOR and NuVasive NUVA . All the stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

THORATEC CORP (THOR): Free Stock Analysis Report

MASIMO CORP (MASI): Free Stock Analysis Report

NUVASIVE INC (NUVA): Free Stock Analysis Report

PRA HEALTH SCI (PRAH): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MASI PRAH NUVA

Other Topics

Stocks

Latest Markets Videos